Related Experiment Video
Updated: Jul 17, 2025

12:31
Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity
Published on: May 1, 2018
13.8K
Mapping Polyclonal Antibody Responses to Infection Using Next-Generation Phage Display.
Maria T Tsoumpeli1, Anitha Varghese1, Jonathan P Owen2
1School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, Leicestershire, UK.
Methods in Molecular Biology (Clifton, N.J.)
|September 7, 2023
Summary
Next-generation phage display (NGPD) identifies pathogen epitopes by mapping polyclonal antibody responses to infection. This method reveals diverse mimotopes, aiding serological assay and vaccine development.
Area of Science:
- Immunology
- Molecular Biology
- Bioinformatics
Background:
- Peptide phage display traditionally maps monoclonal antibodies.
- Next-generation sequencing (NGS) enhances phage display for high-throughput screening.
- Mapping polyclonal antibody responses is crucial for understanding infection immunity.
Purpose of the Study:
- To detail methods for applying next-generation phage display (NGPD) to map polyclonal antibody responses.
- To identify mimotopes representing pathogen epitopes recognized by infected individuals' antibodies.
- To facilitate novel serological assay development and vaccine design.
Main Methods:
- Utilizing next-generation phage display (NGPD) for mass screening of peptide-antibody binding events.
- Applying NGPD to analyze antibody repertoires from individuals with specific infections.
- Identifying and characterizing mimotopes that mimic pathogen epitopes.
Main Results:
- Successful application of NGPD to map polyclonal antibody responses to infection.
- Identification of diverse mimotopes, including linear, conformational, and post-translationally modified epitopes.
- Demonstration of NGPD's capability to represent complex immunological recognition.
Conclusions:
- NGPD is a powerful tool for mapping complex antibody responses to pathogens.
- Identified mimotopes can inform the development of new diagnostic tools and vaccines.
- This methodology advances our understanding of host-pathogen interactions and immune recognition.

